S-Space

Browse

Title

전체 가 나 다 라 마 바 사 아 자 차 카 타 파 하

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Sort by
In order
Results/Page
Authors/record

Showing results 11,141 to 11,160 of 19,875

Issue Date	Title / Author(s) / Citation	File
2019-06	Phase I study of the indoleamine 2,3-dioxygenase 1 (IDO1) inhibitor navoximod (GDC-0919) administered with PD-L1 inhibitor (atezolizumab) in advanced solid tumors Jung, Kyung Hae; LoRusso, Patricia; Burris, Howard; Gordon, Michael; Bang, Yung-Jue; Hellmann, Matthew D.; Cervantes, Andres; Ochoa de Olza, Maria; Marabelle, Aurelien; Hodi, Stephen; Ahn, Myung-Ju; Emens, Leisha A.; Barlesi, Fabrice; Hamid, Omid; Calvo, Emiliano; McDermott, David; Soliman, Hatem; Rhee, Ina; Lin, Ray; Pourmohamad, Tony; Suchomel, Julia; Tsuhako, Amy; Morrissey, Kari; Mahrus, Sami; Morley, Roland; Pirzkall, Andrea; Davis, S. Lindsey Clinical Cancer Research, Vol.25 No.11, pp.3220-3228	DOI
2002-01	Phase I study of weekly docetaxel and cisplatin concurrent with thoracic radiotherapy in stage III non-small-cell lung cancer Wu, Hong Gyun; Bang, Yung-Jue; Choi, Eun Kyung; Ahn, Yong Chan; Kim, Young Whan; Lim, Tae-Hwan; Suh, Cheolwon; Park, Keunchil; Park, Charn Il International Journal of Radiation Oncology Biology Physics, Vol.52 No.1, pp.75-80	DOI
2015-08	Phase I/II study of weekly Oraxol for the second-line treatment of patients with metastatic or recurrent gastric cancer Lee, Keun-Wook; Lee, Kyung Hee; Zang, Dae Young; Park, Young Iee; Shin, Dong Bok; Kim, Jin Won; Im, Seock-Ah; Koh, Sung Ae; Yu, Kyung-Sang; Cho, Joo-Youn; Jung, Jin-A; Bang, Yung-Jue Oncologist, Vol.20 No.8, pp.896-897	DOI
2019-07	Phase Ib study of atezolizumab combined with cobimetinib in patients with solid tumors Hellmann, M. D.; Kim, T. -W.; Lee, C. B.; Goh, B-C; Miller, W. H., Jr.; Oh, D. -Y.; Jamal, R.; Chee, C. -E.; Chow, L. Q. M.; Gainor, J. F.; Desai, J.; Solomon, B. J.; Das Thakur, M.; Pitcher, B.; Foster, P.; Hernandez, G.; Wongchenko, M. J.; Cha, E.; Bang, Y. -J.; Siu, L. L.; Bendell, J. Annals of Oncology, Vol.30 No.7, pp.1134-1142	DOI
2018-11	Phase Ib/II study of capmatinib (INC280) plus gefitinib after failure of epidermal growth factor receptor (EGFR) inhibitor therapy in patients with EGFR-mutated, MET factor-dysregulated non-small-cell lung cancer Wu, Yi-Long; Zhang, Li; Kim, Dong-Wan; Liu, Xiaoqing; Lee, Dae Ho; Yang, James Chih-Hsin; Ahn, Myung-Ju; Vansteenkiste, Johan F.; Su, Wu-Chou; Felip, Enriqueta; Chia, Vincent; Glaser, Sabine; Pultar, Philippe; Zhao, Sylvia; Peng, Bin; Akimov, Mikhail; Tan, Daniel S. W. Journal of Clinical Oncology, Vol.36 No.31, pp.3101-3109	DOI
2018-09	Phase Ib/II study of the pan-cyclin-dependent kinase inhibitor roniciclib in combination with chemotherapy in patients with extensive-disease small-cell lung cancer Cho, Byoung Chul; Dy, Grace K.; Govindan, Ramaswamy; Kim, Dong-Wan; Pennell, Nathan A.; Zalcman, Gerard; Besse, Benjamin; Kim, Joo-Hang; Koca, Goekben; Rajagopalan, Prabhu; Langer, Simon; Ocker, Matthias; Nogai, Hendrik; Barlesi, Fabrice Lung Cancer, Vol.123, pp.14-21	DOI
2012-09	Phase II clinical trial of induction chemotherapy with fixed dose rate gemcitabine and cisplatin followed by concurrent chemoradiotherapy with capecitabine for locally advanced pancreatic cancer Kim, Jae-Sung; Lim, Joo Han; Kim, Jee Hyun; Im, Seock-Ah; Chie, Eui Kyu; Hwang, Jin-Hyeok; Kim, Tae-You; Bang, Yung-Jue; Ha, Sung Whan; Yoon, Yong Bum Cancer Chemotherapy and Pharmacology, Vol.70 No.3, pp.381-389	DOI
1999-10	Phase II clinical trial of SKI-2053R, a new platinum analog, in the treatment of patients with advanced gastric adenocarcinoma Kim, Noe Kyeong; Im, Seock-Ah; Kim, Dong-Wam; Lee, Moon H.; Jung, Chul W.; Cho, Eun K.; Lee, Jong T.; Ahn, Jin S.; Heo, Dae S.; Bang, Yung-Jue Cancer, Vol.86 No.7, pp.1109-1115	DOI
2008-04	Phase II evaluation of CKD-602, a camptothecin analog, administered on a 5-day schedule to patients with platinum-sensitive or -resistant ovarian cancer Lee, Hyo-Pyo; Seo, Sang-Soo; Ryu, Sang-Young; Kim, Jong-Hyeok; Bang, Yung-Jue; Park, Sang-Yoon; Nam, Joo-Hyun; Kang, Soon-Beom; Lee, Kyung-Hee; Song, Yong Sang Gynecol Oncol. 2008;109(3):359-363	link
2008-06	Phase II evaluation of CKD-602, a camptothecin analog, administered on a 5-day schedule to patients with platinum-sensitive or -resistant ovarian cancer Lee, Hyo-Pyo; Seo, Sang-Soo; Ryu, Sang-Young; Kim, Jong-Hyeok; Bang, Yung-Jue; Park, Sang-Yoon; Nam, Joo-Hyun; Kang, Soon-Beorn; Lee, Kyung-Hee; Song, Yong Sang Gynecologic Oncology, Vol.109 No.3, pp.359-363	DOI
2014-03	Phase II randomized trial of neoadjuvant metformin plus letrozole versus placebo plus letrozole for estrogen receptor positive postmenopausal breast cancer (METEOR) Kim, Jisun; Lim, Woosung; Kim, Eun-Kyu; Kim, Min-Kyoon; Paik, Nam-Sun; Jeong, Sang-Seol; Yoon, Jung-han; Park, Chan Heun; Ahn, Sei Hyun; Kim, Lee Su; Han, Sehwan; Nam, Seok Jin; Kang, Han-Sung; Kim, Seung Il; Yoo, Young Bum; Jeong, Joon; Kim, Tae Hyun; Kang, Taewoo; Kim, Sung-Won; Jung, Yongsik; Lee, Jeong Eon; Kim, Ku Sang; Yu, Jong-Han; Chae, Byung Joo; Jung, So-Youn; Kang, Eunyoung; Choi, Su Yun; Moon, Hyeong-Gon; Noh, Dong-Young; Han, Wonshik BMC Cancer Vol.14, pp.1-5	view file DOI
2014-03	Phase II randomized trial of neoadjuvant metformin plus letrozole versus placebo plus letrozole for estrogen receptor positive postmenopausal breast cancer (METEOR) Kim, Jisun; Lim, Woosung; Kim, Eun-Kyu; Kim, Min-Kyoon; Paik, Nam-Sun; Jeong, Sang-Seol; Yoon, Jung-han; Park, Chan Heun; Ahn, Sei Hyun; Kim, Lee Su; Han, Sehwan; Nam, Seok Jin; Kang, Han-Sung; Kim, Seung Il; Yoo, Young Bum; Jeong, Joon; Kim, Tae Hyun; Kang, Taewoo; Kim, Sung-Won; Jung, Yongsik; Lee, Jeong Eon; Kim, Ku Sang; Yu, Jong-Han; Chae, Byung Joo; Jung, So-Youn; Kang, Eunyoung; Choi, Su Yun; Moon, Hyeong-Gon; Noh, Dong-Young; Han, Wonshik BMC Cancer, 14(1):170	view file DOI
2009-01	Phase II study and biomarker analysis of cetuximab combined with modified FOLFOX6 in advanced gastric cancer Han, S-W; Oh, D-Y; Im, S-A; Park, S R; Lee, K-W; Song, H S; Lee, N-S; Lee, K H; Choi, I S; Lee, M H; Kim, M A; Kim, W H; Bang, Y-J; Kim, T-Y Br J Cancer. 2009 Jan 27;100(2):298-304. Epub 2009 Jan 6.	link
2009-01	Phase II study and biomarker analysis of cetuximab combined with modified FOLFOX6 in advanced gastric cancer Han, S-W; Oh, D-Y; Im, S-A; Park, S. R.; Lee, K-W; Song, H. S.; Lee, N-S; Lee, K. H.; Choi, I. S.; Lee, M. H.; Kim, M. A.; Kim, W. H.; Bang, Y-J; Kim, T-Y British Journal of Cancer, Vol.100 No.2, pp.298-304	DOI
2024-04	Phase II study investigating the efficacy and safety of glesatinib (MGCD265) in patients with advanced NSCLC containing MET activating alterations Hong, David S.; Cappuzzo, Federico; Chul Cho, Byoung; Dowlati, Afshin; Hussein, Maen; Kim, Dong-Wan; Percent, Ivor; Christensen, James G.; Morin, Josée; Potvin, Diane; Faltaos, Demiana; Tassell, Vanessa; Der-Torossian, Hirak; Chao, Richard Lung Cancer, Vol.190, p. 107512	DOI
2007	Phase II study of 5-fluorouracil and cisplatin systemic chemotherapy for inoperable hepatocellular carcinoma 김범석	link
2021-02	Phase II Study of Avelumab in Patients with Advanced Hepatocellular Carcinoma Previously Treated with Sorafenib Lee, Dae-Won; Cho, Eun Ju; Lee, Jeong-Hoon; Yu, Su Jong; Kim, Yoon Jun; Yoon, Jung-Hwan; Kim, Tae-Yong; Han, Sae-Won; Oh, Do Youn; Im, Seock-Ah; Kim, Tae-You; Lee, Youngeun; Kim, Haeryoung; Lee, Kyung-Hun Clinical Cancer Research, Vol.27 No.3, pp.713-718	DOI
2007-07	Phase II study of biweekly paclitaxel and cisplatin combination chemotherapy in advanced gastric cancer: Korea-Japan collaborative study group trial Kim, Yeul Hong; Yamaguchi, Kensei; Bang, Yung-Jue; Takiuchi, Hiroya; Kang, Won Ki; Sato, Atsushi; Kang, Yoon-Koo; Sakamoto, Junichi; Abe, Chigusa; Sakata, Yuh Japanese Journal of Clinical Oncology, Vol.37 No.7, pp.501-508	DOI
2011-06	Phase II study of biweekly S-1 and oxaliplatin combination chemotherapy in metastatic colorectal cancer and pharmacogenetic analysis Hong, Junshik; Han, Sae-Won; Ham, Hye Seon; Kim, Tae-Yong; Choi, In Sil; Kim, Byung-Su; Oh, Do-Youn; Im, Seock-Ah; Kang, Gyeong Hoon; Bang, Yung-Jue; Kim, Tae-You Cancer Chemotherapy and Pharmacology, Vol.67 No.6, pp.1323-1331	DOI
2002	Phase II study of chemotherapy with ACNU plus cisplatin followed by cranial irradiation in patients with newly diagnosed glioblastoma multiforme Choi, In Sil; Lee, Se Hoon; Kim, Tae-You; Bang, Jae Seug; Paek, Sun Ha; Kim, Suzy; Kim, Il Han; Heo, Dae Seog; Bang, Yung-Jue; Kim, Dong Gyu; Jung, Hee-Won; Kim, Noe Kyeong J Neurooncol 60: 171-176	link

1 555 556 557 558 559 560 561 994